Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Brain Pathology (Zurich, Switzerland)|July 27, 2019
Identification of prognostic markers in diffuse midline gliomas H3K27M-mutantCharlotte Dufour, Romain Perbet, Pierre Leblond, et al.
Bulletin Du Cancer|October 8, 2013
[Comparative cost analysis of molecular biology methods in the diagnosis of sarcomas]Sandrine Baffert, Antoine Italiano, Gaëlle Pierron, et al.
Clinical Lung Cancer|June 1, 2019
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine PracticePhilippe Jamme, Clotilde Descarpentries, Radj Gervais, et al.
European Journal of Human Genetics : EJHG|December 16, 2018
Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variantsClémence Vanlerberghe, Anne-Sophie Jourdain, Jamal Ghoumid, et al.
Acta Neuropathologica Communications|March 19, 2023
Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion"Laetitia Lebrun, Sacha Allard-Demoustiez, Nathalie Gilis, et al.
European Journal of Human Genetics : EJHG|May 10, 2025
Townes-Brocks syndrome: genotype-phenotype correlations of SALL1 variants in our series and the literatureFiona Leduc, Perrine Brunelle, Fabienne Escande, et al.
Nature Communications|November 5, 2022
Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survivalMarie Duhamel, Lauranne Drelich, Maxence Wisztorski, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 13, 2024
Functional characterization vs in silico prediction for TBX5 missense and splice variants in Holt-Oram syndromeClémence Vanlerberghe, Anne Sophie Jourdain, Frédéric Frenois, et al.
Pageof 8